Trials / Unknown
UnknownNCT06189326
Non-penetrating Deep Sclerectomy Versus Trabeculotomy- Trabeculectomy Operation in Treatment of Primary Congenital Glaucoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 1 Year – 20 Years
- Healthy volunteers
- Not accepted
Summary
The high success rate of the non-penetrating deep sclerectomy (NPDS) procedure in adult glaucomatous patients motivated some glaucoma specialists to try it as an alternative procedure in childhood PCG. In deep sclerectomy, the surgeon fashions a partial-thickness scleral flap and excises the outer parts of both Schlemm's canal and trabecular meshwork without opening the eye, leaving a thin trabeculo-descemetic membrane. This membrane will guard against early postoperative hypotony due to the non-penetrating nature of the procedure. The aim of this study is to assess the safety and efficacy outcomes of non-penetrating deep sclerectomy versus combined trabeculotomy-trabeculectomy in the treatment of congenital primary glaucoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | non-penetrating deep sclerectomy | Non-penetrating deep sclerectomy (NPDS) is a non-perforating filtration procedure used for the surgical treatment of medically uncontrolled open angle glaucoma. This procedure was developed in an attempt to avoid many of the postoperative complications of trabeculectomy |
| PROCEDURE | primary combined trabeculotomy-trabeculectomy | Combining trabeculotomy with trabeculectomy is one of the preferred surgical options, which showed favorable results in congenital glaucoma, and is advised mainly for treating moderate to severe forms of the disease, as the procedure provides dual pathways for aqueous drainage |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-12-01
- Completion
- 2024-02-01
- First posted
- 2024-01-03
- Last updated
- 2024-01-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06189326. Inclusion in this directory is not an endorsement.